Phreesia’s (PHR) “Sector Perform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reiterated their sector perform rating on shares of Phreesia (NYSE:PHR) in a research report sent to investors on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $23.00 price objective on the stock.

Several other analysts have also commented on PHR. DA Davidson reissued a buy rating and set a $32.00 target price on shares of Phreesia in a research note on Thursday. Needham & Company LLC reiterated a buy rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday. JMP Securities restated a market outperform rating and issued a $30.00 target price on shares of Phreesia in a report on Friday, August 30th. Stephens reaffirmed an overweight rating and set a $28.00 target price on shares of Phreesia in a report on Friday, May 31st. Finally, Canaccord Genuity Group reissued a buy rating and issued a $34.00 price target on shares of Phreesia in a research note on Thursday. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus target price of $30.42.

Phreesia Price Performance

Shares of Phreesia stock opened at $23.55 on Thursday. Phreesia has a 52 week low of $12.05 and a 52 week high of $29.16. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.03. The company’s 50-day moving average price is $23.38 and its two-hundred day moving average price is $22.77. The stock has a market cap of $1.35 billion, a PE ratio of -10.85 and a beta of 0.93.

Insider Activity at Phreesia

In related news, CEO Chaim Indig sold 2,644 shares of Phreesia stock in a transaction on Tuesday, July 16th. The stock was sold at an average price of $23.74, for a total transaction of $62,768.56. Following the completion of the sale, the chief executive officer now owns 1,219,361 shares of the company’s stock, valued at $28,947,630.14. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, CEO Chaim Indig sold 2,644 shares of the firm’s stock in a transaction that occurred on Tuesday, July 16th. The shares were sold at an average price of $23.74, for a total transaction of $62,768.56. Following the transaction, the chief executive officer now owns 1,219,361 shares of the company’s stock, valued at $28,947,630.14. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, General Counsel Allison C. Hoffman sold 14,110 shares of Phreesia stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $26.03, for a total transaction of $367,283.30. Following the completion of the sale, the general counsel now owns 121,003 shares of the company’s stock, valued at $3,149,708.09. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,337 shares of company stock valued at $736,750. Corporate insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of PHR. Vanguard Group Inc. increased its holdings in shares of Phreesia by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 4,628,441 shares of the company’s stock valued at $107,148,000 after acquiring an additional 194,035 shares during the last quarter. Champlain Investment Partners LLC acquired a new position in Phreesia during the first quarter valued at approximately $29,941,000. Brown Advisory Inc. raised its position in shares of Phreesia by 22.2% in the fourth quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after purchasing an additional 716,374 shares during the period. Boston Partners acquired a new stake in shares of Phreesia in the first quarter worth $669,000. Finally, Blair William & Co. IL lifted its stake in shares of Phreesia by 42.6% in the first quarter. Blair William & Co. IL now owns 752,700 shares of the company’s stock worth $18,012,000 after buying an additional 224,950 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.